Suntou-gun, Japan

Tadakazu Akiyama

This inventor holds 4 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadakazu Akiyama. Retrieved from https://idiyas.com/inventor/tadakazu-akiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Shizuoka, JP (2001 - 2003)
  • Sunto-gun, JP (2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Tadakazu Akiyama

Introduction

Tadakazu Akiyama, a prominent inventor based in Sunto-gun, Japan, has made significant contributions to the field of biotechnology. With a total of four patents to his name, Akiyama is recognized for his innovative work in developing pharmaceutical compounds.

Latest Patents

Akiyama's latest patents include derivatives of Staurosporin and Radicicol, both of which play a crucial role in advancing medical and therapeutic applications. These discoveries reflect his dedication to improving health outcomes and showcasing his expertise in biochemical innovation.

Career Highlights

Tadakazu Akiyama is affiliated with Kyowa Hakko Kogyo Co., Ltd., a company renowned for its commitment to biopharmaceutical research and development. His career at this company has been marked by a focus on creating novel compounds that hold promise for future therapies.

Collaborations

Throughout his career, Akiyama has collaborated with esteemed colleagues, including Nobuyoshi Amishiro and Chikara Murakata. These partnerships highlight the spirit of teamwork and collaboration that is vital in the field of innovative research.

Conclusion

In summary, Tadakazu Akiyama stands out as a notable inventor with a strong portfolio of patents and meaningful collaborations. His contributions are instrumental in developing new therapies, and he continues to inspire future generations of innovators in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…